Estrogen Plus Progestin and Colorectal Cancer Incidence and Mortality

PURPOSE: During the intervention phase in the Women's Health Initiative (WHI) clinical trial, use of estrogen plus progestin reduced the colorectal cancer diagnosis rate, but the cancers were found at a substantially higher stage. To assess the clinical relevance of the findings, analyses of th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Simon, Michael S., Chlebowski, Rowan T., Wactawski-Wende, Jean, Johnson, Karen C., Muskovitz, Andrew, Kato, Ikuko, Young, Alicia, Hubbell, F. Allan, Prentice, Ross L.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2012
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3488271/
https://ncbi.nlm.nih.gov/pubmed/23008295
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2012.42.7732
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados